INHIBITORS OF HEPATITIS C VIRUS
Macrocyclic peptides are disclosed having the general formula: (I) wherein R<SUB>3</SUB>, R'<SUB>3, </SUB>R<SUB>4</SUB>, R<SUB>6</SUB>, R', X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.